Risedronate and blood urea increased Patient Reports February 12, 2012

Risedronate Side Effects Report #5030741-7
Risedronate side effect was reported by a Physician from JAPAN on May 18, 2006. Female patient, 81 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bacterial infection , blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased, blood urea increased, cardiac failure, haemoptysis. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with LOXONIN, CODEINE PHOSPHATE, HUSTAZOL, MAGNESIUM OXIDE, ULGUT, LEVOFLOXACIN. Patient was hospitalized. Patient died on 04/20/2006.

Risedronate Side Effects Report #5890688-0
Risedronate side effect was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2008. Female patient, 73 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood urea increased, decreased appetite, gastritis erosive, jaundice , liver disorder. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ALFAROL, ASPARA, ZOLPIDEM TARTRATE, ETODOLAC, METHYCOBAL, SOLON, CRESTOR, EPADEL. Patient recovered.

Risedronate Side Effects Report #5954623-9
Risedronate side effect was reported by a Physician from JAPAN on Oct 27, 2008. Female patient, 72 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ammonia increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, gamma-glutamyltransferase increased, hepatic function abnormal, hypersensitivity. Risedronate dosage: 2.5 MG ONCE DAILY, ORAL. During the same period patient was treated with VOLTAREN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5023449-5
Risedronate side effect was reported by a Physician from JAPAN on May 23, 2006. Female patient, 69 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholesterol increased, blood creatinine increased, blood pressure decreased, blood urea increased, cardiomegaly, chest discomfort, chest pain . Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ZOLPIDEM TARTRATE, DEPAS, DICLOFENAC. Patient was hospitalized. Patient recovered.